These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
490 related articles for article (PubMed ID: 6704960)
21. Estradiol and tamoxifen differently affects the inhibitory effects of vitamin A and their metabolites on the proliferation and expression of alpha2beta1 integrins in MCF-7 breast cancer cells. Czeczuga-Semeniuk E; Lemancewicz D; Wołczyński S Adv Med Sci; 2009; 54(1):91-8. PubMed ID: 19581203 [TBL] [Abstract][Full Text] [Related]
22. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro. Reddel RR; Murphy LC; Sutherland RL Cancer Res; 1983 Oct; 43(10):4618-24. PubMed ID: 6883318 [TBL] [Abstract][Full Text] [Related]
23. Effects of 1,25-dihydroxyvitamin D3 on cell-cycle kinetics of T 47D human breast cancer cells. Eisman JA; Sutherland RL; McMenemy ML; Fragonas JC; Musgrove EA; Pang GY J Cell Physiol; 1989 Mar; 138(3):611-6. PubMed ID: 2925799 [TBL] [Abstract][Full Text] [Related]
24. Effect of alpha-interferon, 17 beta-estradiol, and tamoxifen on estrogen receptor concentration and cell cycle kinetics of MCF 7 cells. Bezwoda WR; Meyer K Cancer Res; 1990 Sep; 50(17):5387-91. PubMed ID: 2386944 [TBL] [Abstract][Full Text] [Related]
25. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells. Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. Furuya Y; Kohno N; Fujiwara Y; Saitoh Y Cancer Res; 1989 Dec; 49(23):6670-4. PubMed ID: 2819716 [TBL] [Abstract][Full Text] [Related]
27. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture. Jain PT; Pento JT; Magarian RA Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114 [TBL] [Abstract][Full Text] [Related]
28. Effects of tamoxifen on potential doubling time of human breast cancer cell line determined by image cytometry of double fluorescent BrdU and DNA labeling. Rostagno P; Moll JL; Birtwisle-Peyrottes I; Ettore F; Lagrange JL; Gioanni J; Caldani C Anticancer Res; 1994; 14(5A):2025-32. PubMed ID: 7531416 [TBL] [Abstract][Full Text] [Related]
29. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal. Lewis JS; Osipo C; Meeke K; Jordan VC J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958 [TBL] [Abstract][Full Text] [Related]
30. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Brünner N; Bronzert D; Vindeløv LL; Rygaard K; Spang-Thomsen M; Lippman ME Cancer Res; 1989 Mar; 49(6):1515-20. PubMed ID: 2924304 [TBL] [Abstract][Full Text] [Related]
31. Effects of estradiol and tamoxifen on human breast cancer cells in serum-free culture. Darbre PD; Curtis S; King RJ Cancer Res; 1984 Jul; 44(7):2790-3. PubMed ID: 6722808 [TBL] [Abstract][Full Text] [Related]
32. Effects of estrogen and tamoxifen on the regulation of dihydrofolate reductase gene expression in a human breast cancer cell line. Levine RM; Rubalcaba E; Lippman ME; Cowan KH Cancer Res; 1985 Apr; 45(4):1644-50. PubMed ID: 3978632 [TBL] [Abstract][Full Text] [Related]
33. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [TBL] [Abstract][Full Text] [Related]
34. Estradiol induction of retinoic acid receptors in human breast cancer cells. Roman SD; Ormandy CJ; Manning DL; Blamey RW; Nicholson RI; Sutherland RL; Clarke CL Cancer Res; 1993 Dec; 53(24):5940-5. PubMed ID: 8261407 [TBL] [Abstract][Full Text] [Related]
35. Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. Sutherland RL; Hall RE; Pang GY; Musgrove EA; Clarke CL Cancer Res; 1988 Sep; 48(18):5084-91. PubMed ID: 2970295 [TBL] [Abstract][Full Text] [Related]
36. Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Taylor IW; Hodson PJ; Green MD; Sutherland RL Cancer Res; 1983 Sep; 43(9):4007-10. PubMed ID: 6871842 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells. Gong Y; Ballejo G; Murphy LC; Murphy LJ Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100 [TBL] [Abstract][Full Text] [Related]
38. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Lippman M; Bolan G; Huff K Cancer Res; 1976 Dec; 36(12):4595-601. PubMed ID: 1000504 [TBL] [Abstract][Full Text] [Related]
39. Growth factor-like activity of phenol red preparations in the MCF-7 breast cancer cell line. Devleeschouwer N; Body JJ; Legros N; Muquardt C; Donnay I; Wouters P; Leclercq G Anticancer Res; 1992; 12(3):789-94. PubMed ID: 1622138 [TBL] [Abstract][Full Text] [Related]
40. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. Strobl JS; Kirkwood KL; Lantz TK; Lewine MA; Peterson VA; Worley JF Cancer Res; 1990 Sep; 50(17):5399-405. PubMed ID: 2386945 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]